News
HVP – More than 100 Lives Reported Saved Since Launch of the “kaleo Cares” EVZIO® (naloxone HCl injection) Donation Program
RICHMOND, Va., Aug. 31, 2015 /PRNewswire/ — Kaléo, a privately-held pharmaceutical company, today announced that EVZIO® (naloxone HCl injection) Auto-Injectors—donated through their charitable donation program, “kaléo Cares,”—have been administered to help save more than 100 lives since inception of the charitable program. EVZIO is the only naloxone product approved for immediate administration as emergency therapy in settings where opioids may be present, such as in a home where most opioid overdose emergencies occur.
To view the full article, please click here.